Sintetica logo — Improving therapies 
through innovative solutions
driven by...

Sintetica

Improving therapies through innovative solutions driven by clinicians’ insights to meet patients’ needs.

Founded 1921 Switzerland Mendrisio, Switzerland 321 employees Biotechnology, Pharmaceutical

General Information

Company Name Sintetica
Founded Year 1921
Location Switzerland Mendrisio, Switzerland
Employees 321
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Sintetica. To contact Sintetica, visit sintetica.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Sintetica compare?

A PDF of Sintetica and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Sintetica soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Sintetica

Sintetica is a Swiss pharmaceutical company that has been established in 1921. The company is dedicated to innovating therapies and drugs in anesthesia, pain management, intensive care, and neuromodulation. Their slogan, "Improving therapies through innovative solutions driven by clinicians’ insights to meet patients’ needs," reflects their commitment to leveraging clinical perspectives for impactful solutions.

With a focus on biotechnology and pharmaceuticals, Sintetica is at the forefront of developing cutting-edge medical treatments.

Although no specific details are available regarding their last investment or investors, the company's long-standing presence in the industry and dedication to innovation make it an attractive potential investment opportunity in the pharmaceutical sector. Based in Switzerland, Sintetica is poised to continue making significant strides in improving healthcare through its innovative approach to drug development.

Business keywords: pharmaceutical, therapies, innovation, anaesthesia, pain management, intensive care, neuromodulation

No funding data available for Sintetica yet.

Sintetica Alternatives & Competitors

Sintetica vs

Empowering therapies for cancer and neurologic diseases through pioneering ion channel inhibition

Series A
Biotechnology, Health Care
Sintetica vs

Achieve better treatment processes and outcomes by combining global expertise and strength in endocr...

Series B
42 employees
Biotechnology, Life Sciences
Sintetica vs

Developing innovative CNS and pain therapies that significantly address unmet medical needs.

Post-IPO Debt
201-500 employees
Biotechnology, Health Care

FAQ About Sintetica

Improving therapies through innovative solutions driven by clinicians’ insights to meet patients’ needs.
Sintetica was founded in 1921.
Sintetica is headquartered in Mendrisio, Switzerland.
Sintetica operates in Biotechnology and Pharmaceutical. Its work centres on pharmaceutical, therapies, innovation and anaesthesia.
Sintetica has approximately 321 employees.
Top alternatives and competitors to Sintetica include Cavion, VISEN Pharmaceuticals, Zogenix, IASO Biotechnology(驯鹿生物), Semnur Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sintetica and Cavion are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sintetica, https://bouncewatch.com/company/sintetica, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes